Search results for "acquity"

The 1.7 µm Ethylene Bridged Hybrid [BEH] particle is one of the key enablers behind UPLC® technology.It is available in three different pore sizes [130Å, 200Å and 300Å] and several bonded phases for reversed-phase and hydrophilic interaction chromatography and is applicable from small molecule to large biopharmaceutical analysis. Due to the intrinsic chemical stability of hybrid particle technology, a wider usable pH range [pH…

The ACQUITY UPLC® M-Class System with HDX Technology leverages UPLC® separations and high-resolution MS to answer important questions about changes in protein conformation including: Drug candidate binding to a protein Biopharmaceutical product development Protein-protein interactions Intellectual Property The unprecedented system-level design integrates all the steps necessary to accurately, reproducibly, and most o…

Anion exchange, reverse-phase columns that provide charged-based separations and extra resolution for acidic glycans. With MaxPeak High Performance surfaces that reduce non-specific adsorption.

Size-based separations of peptides. proteins, and viral vectors

Making more informed decisions in less time is a universal asset in today's laboratory. Ultra Performance LC™ (UPLC™ ), a new category of separation science pioneered by Waters, will eliminate significant time and cost per sample from your analytical process—while improving the quality of your results. With UPLC technology you benefit from: more data, faster unparalleled sensitivity greater efficiency and confidence in…

Diastereoselective Separation of Permethrin Using the ACQUITY UPC2 System

With patented StepWave technology, our highest performance IVD instrument provides ultimate sensitivity, to accurately quantify trace analytes in the most complex of clinical matrices encountered

Next-generation UPLC platform designed to keep pace with evolving laboratory requirements for chromatographic performance